Athos Therapeutics is a clinical-stage biotech focused primarily on developing precision small molecule therapeutics for autoimmune diseases and chronic inflammatory diseases. Like a growing number of biotechs, Athos is giving machine learning a prominent role in its drug discovery approach. Its advanced AI/ML platform integrates patient samples and data from global hospital systems to identify…
At AWS re:Invent, Pfizer exec frames digital as a core business strategy
In the midst of a global pandemic, Pfizer, under the leadership of its chief digital and technology officer Lidia Fonseca, achieved what was once thought impossible. The company, with the partnership of BioNTech, developed a COVID-19 vaccine in only 269 days, a process that traditionally would have taken 8 to 10 years. While prior research…
Working backwards: AWS’s strategy for pharma’s cloud-enabled transformation
The meteoric rise of the AI sector is hard to fathom. Projections from Precedence Research suggest that the global AI market could balloon by 2600% from 2022 to 2032, hitting $1.87 trillion — an annual growth rate of 39%. In pharma, AI and data science demand is surging though overall growth is sluggish. Despite advances…